Inhibition of autophagy curtails visual loss in a model of autosomal dominant optic atrophy.
Marta ZaninelloKonstantinos PalikarasDeborah NaonKeiko IwataStephanie HerkenneRubèn Quintana-CabreraMartina SemenzatoFrancesca GrespiFred N Ross-CisnerosValerio CarelliAlfredo A SadunNektarios TavernarakisLuca ScorranoPublished in: Nature communications (2020)
In autosomal dominant optic atrophy (ADOA), caused by mutations in the mitochondrial cristae biogenesis and fusion protein optic atrophy 1 (Opa1), retinal ganglion cell (RGC) dysfunction and visual loss occur by unknown mechanisms. Here, we show a role for autophagy in ADOA pathogenesis. In RGCs expressing mutated Opa1, active 5' AMP-activated protein kinase (AMPK) and its autophagy effector ULK1 accumulate at axonal hillocks. This AMPK activation triggers localized hillock autophagosome accumulation and mitophagy, ultimately resulting in reduced axonal mitochondrial content that is restored by genetic inhibition of AMPK and autophagy. In C. elegans, deletion of AMPK or of key autophagy and mitophagy genes normalizes the axonal mitochondrial content that is reduced upon mitochondrial dysfunction. In conditional, RGC specific Opa1-deficient mice, depletion of the essential autophagy gene Atg7 normalizes the excess autophagy and corrects the visual defects caused by Opa1 ablation. Thus, our data identify AMPK and autophagy as targetable components of ADOA pathogenesis.
Keyphrases
- oxidative stress
- cell death
- endoplasmic reticulum stress
- protein kinase
- signaling pathway
- skeletal muscle
- spinal cord injury
- optical coherence tomography
- genome wide
- gene expression
- stem cells
- mesenchymal stem cells
- copy number
- dendritic cells
- electronic health record
- deep learning
- dna methylation
- regulatory t cells
- big data
- cell therapy
- genome wide identification
- radiofrequency ablation